English teacher Mary Rodgers kicked off her 12th grade honors English class at Louisa County High School in Virginia with an activity that some of her colleagues around the country would find ...

Shares of Palantir Technologies (PLTR) spent Tuesday trading in a narrow range, mirroring the stock’s behavior over the past 20 trading sessions. While some investors may interpret this sideways ...

A curious pup accidentally started a fire at his owner's home in Chapel Hill, North Carolina after chewing on a rechargeable power bank, the local fire department said. Zootopia 2 final trailer ...

Unfortunately for collectors, most of the cards they picked up in 1989 are barely worth the cardboard they're printed on, hence the "Junk Wax Era" moniker. However, a notable outlier is the Upper Deck ...

In 1986, the people of Cameroon woke to an unthinkable nightmare. Lake Nyos, a seemingly calm body of water, had silently released a massive cloud of carbon dioxide, suffocating more than 1,700 people ...

The day isn't far when cars could become part of a person's investment portfolio, given how some models grow exponentially in value over time. The volatile market situation is also a great excuse to ...

The stock does seem overvalued, but you might still invest in it -- one way or another. There's that steep price, though, right? I see several ways you can approach the stock, depending on your risk ...

Welcome to Locked on Ole Miss with Steven Willis! 🏈 Lane Kiffin rumors swirl as Ole Miss gears up for a crucial Oklahoma showdown.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Micron Technology (NASDAQ:MU) has emerged as a key player ...

When Mitsubishi made your first cellphone, you know you’ve been around a while. Steve has carried the latest and greatest around in his pocket for nearly 30 years, with everything from Motorola ...

Iovance Biotherapeutics was the first drug developer to win FDA approval of an immune cell/T-cell therapy. The underlying science, however, may offer more long-term potential than the single drug in ...